Cardiac Troponin and Risk Stratification in Ischemic Heart Disease.
N Engl J Med. 2015 Aug 13;373(7):672-674
Authors: Melloni C, Roe MT
Abstract
Early, first-generation and second-generation cardiac troponin assays were shown to improve the accuracy of the diagnosis of acute myocardial infarction and enhance the risk stratification of patients with suspected ischemic symptoms by means of a more precise identification of myocardial necrosis.(1),(2) The first universal definition of myocardial infarction, published in 2000, defined laboratory thresholds for the designation of elevated cardiac troponin values to clarify the diagnosis of myocardial infarction in a patient with suspected myocardial ischemia.(3) In a similar fashion, the guidelines for unstable angina and non-ST-segment elevation myocardial infarction in the United States and Europe incorporated cardiac troponin . . .
PMID: 26267628 [PubMed - as supplied by publisher]